PHARMACOVIGILANCE
We meet the highest standards required to ensure the safe distribution of our products.
Pharmacovigilance consists of a set of activities related to the identification, evaluation, understanding and prevention of adverse reactions or any other safety problem that may be linked to the use of medicinal products. The spontaneous reporting of suspected adverse drug reactions is a fundamental source of information for pharmacovigilance activities.
What is an adverse drug reaction?
It is a harmful and unwanted response to a medicinal product and can result from a use of the medicinal product authorised or not authorised (e.g. overdose, misuse, abuse, therapeutic error, off-label) or from occupational exposure.
How to report a suspected adverse reaction
Every European Member State has specific laws governing the reporting of suspected adverse drug reactions. If you experience an adverse drug reaction with Aspargo Labs Italia medicinal products authorised in a specific Member State, you shall report the suspected adverse drug reaction according to the local legislation, as below indicated.
Spain
Please follow the indication reported on the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) website, in the section dedicated to adverse reaction reporting.
Please report the suspected adverse drug reaction directly to Aspargo Labs Italia. To contact the Aspargo Labs Italia pharmacovigilance team, please fill in the form as indicated below. You will be asked to confirm that you have read the policy on the treatment of personal data before forwarding the message.